COVID-19 and the heart : An update for clinicians
© 2020 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc..
SARS-CoV-2, the cause of the COVID-19 pandemic has significantly impacted cardiovascular healthcare. Patients with pre-existing cardiovascular disease are at higher risk of morbidity and mortality. The virus may affect the heart directly and indirectly with clinical syndromes of acute myocardial injury, myocarditis, acute coronary syndromes, heart failure, arrhythmias, and venous thromboembolism. Some therapeutics under investigation for COVID-19 may also have adverse cardiac effects. The involvement of the RAAS system in viral entry makes it pertinent to consider the effects of medications that modulate the system. Comprehensive knowledge of peculiar cardiovascular manifestations of COVID-19 and the role of RAAS in the prognosis of COVID-19 disease is needed for optimal patient management.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Clinical cardiology - 43(2020), 11 vom: 21. Nov., Seite 1216-1222 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Goha, Ahmed [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acute myocardial injury |
|---|
| Anmerkungen: |
Date Completed 19.11.2020 Date Revised 12.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/clc.23406 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311127150 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311127150 | ||
| 003 | DE-627 | ||
| 005 | 20231225141606.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/clc.23406 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1037.xml |
| 035 | |a (DE-627)NLM311127150 | ||
| 035 | |a (NLM)32533585 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Goha, Ahmed |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 and the heart |b An update for clinicians |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.11.2020 | ||
| 500 | |a Date Revised 12.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc. | ||
| 520 | |a SARS-CoV-2, the cause of the COVID-19 pandemic has significantly impacted cardiovascular healthcare. Patients with pre-existing cardiovascular disease are at higher risk of morbidity and mortality. The virus may affect the heart directly and indirectly with clinical syndromes of acute myocardial injury, myocarditis, acute coronary syndromes, heart failure, arrhythmias, and venous thromboembolism. Some therapeutics under investigation for COVID-19 may also have adverse cardiac effects. The involvement of the RAAS system in viral entry makes it pertinent to consider the effects of medications that modulate the system. Comprehensive knowledge of peculiar cardiovascular manifestations of COVID-19 and the role of RAAS in the prognosis of COVID-19 disease is needed for optimal patient management | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a NSAID | |
| 650 | 4 | |a RAAS | |
| 650 | 4 | |a acute myocardial injury | |
| 650 | 4 | |a myocaritis | |
| 700 | 1 | |a Mezue, Kenechukwu |e verfasserin |4 aut | |
| 700 | 1 | |a Edwards, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Nunura, Felix |e verfasserin |4 aut | |
| 700 | 1 | |a Baugh, Dainia |e verfasserin |4 aut | |
| 700 | 1 | |a Madu, Ernest |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical cardiology |d 1992 |g 43(2020), 11 vom: 21. Nov., Seite 1216-1222 |w (DE-627)NLM000419834 |x 1932-8737 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2020 |g number:11 |g day:21 |g month:11 |g pages:1216-1222 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/clc.23406 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2020 |e 11 |b 21 |c 11 |h 1216-1222 | ||